Figures computed from official regulatory filings — .
Analysttarget 17.8 USD (+20%) · consensus 4.4/5 · 4 buy · 1 hold · 0 sell
Ownershipinsiders 30.51% · institutions 9.22% · short 5.4% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Alpha Tau Medical Ltd. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
12 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Levy Raphi | Exercise | $8.6K | SEC |
| Levy Raphi | Sell | $43.1K | SEC |
| Levy Raphi | Exercise | $52.8K | SEC |
| Levy Raphi | Sell | $248.3K | SEC |
| Levy Raphi | Exercise | $6.8K | SEC |
| Levy Raphi | Sell | $31.8K | SEC |
| Levy Raphi | Exercise | $53.3K | SEC |
| Levy Raphi | Sell | $232.4K | SEC |
| Levy Raphi | Sell | $27.7K | SEC |
| Levy Raphi | Exercise | $6.3K | SEC |
| Levy Raphi | Sell | $240K | SEC |
| Levy Raphi | Sell | $173.6K | SEC |
| Levy Raphi | Sell | $46.4K | SEC |
| Levy Raphi | Sell | $142.1K | SEC |
| Levy Raphi | Sell | $25K | SEC |
| Levy Raphi | Sell | $190.8K | SEC |
| Levy Raphi | Sell | $161.4K | SEC |